{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:08:09Z","timestamp":1774393689535,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":2927,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1111\/jth.12726","type":"journal-article","created":{"date-parts":[[2014,9,11]],"date-time":"2014-09-11T09:37:22Z","timestamp":1410428242000},"page":"1850-1860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-9656","authenticated-orcid":false,"given":"S.","family":"Weisshaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Litschauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gouya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Smerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kapiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"Kyrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wolzt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12726_bb0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehp492","article-title":"Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries","volume":"31","author":"Widimsky","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12726_bb0015","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST\u2010segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12726_bb0020","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12726_bb0025","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST\u2010elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1111\/jth.12726_bb0030","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.113.002589","article-title":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial","volume":"128","author":"Steg","year":"2013","journal-title":"Circulation"},{"key":"10.1111\/jth.12726_bb0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12726_bb0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12726_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/jth.12726_bb0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12726_bb0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.amjcard.2011.11.013","article-title":"The editor's roundtable: medical management of atrial fibrillation","volume":"109","author":"Friedewald","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.12726_bb0060","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/europace\/eum191","article-title":"Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association","volume":"9","author":"Kirchhof","year":"2007","journal-title":"Europace"},{"key":"10.1111\/jth.12726_bb0065","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"Lip","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12726_bb0070","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurheartj\/ehl488","article-title":"Safety and efficacy of combined antiplatelet\u2010warfarin therapy after coronary stenting","volume":"28","author":"Karjalainen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12726_bb0075","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis","volume":"51","author":"Ruiz\u2010Nodar","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12726_bb0080","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/jth.12726_bb0085","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"key":"10.1111\/jth.12726_bb0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/clc.22254","article-title":"One\u2010year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry","volume":"37","author":"Rubboli","year":"2014","journal-title":"Clin Cardiol"},{"key":"10.1111\/jth.12726_bb0095","doi-asserted-by":"crossref","DOI":"10.5603\/CJ.a2013.0146","article-title":"Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: data from the Berlin AFibACS Registry","author":"Maier","year":"2014","journal-title":"Cardiol J"},{"key":"10.1111\/jth.12726_bb0100","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open\u2010label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/jth.12726_bb0105","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jacc.2010.09.013","volume":"57","author":"Fuster","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12726_bb0110","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence\u2010Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.12726_bb0115","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12726_bb0120","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2012.02.008","article-title":"New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis\u2010Task Force on Anticoagulants in Heart Disease Position Paper","volume":"59","author":"De Caterina","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12726_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0038-1651063","article-title":"Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man\u2013effect of low\u2010dose aspirin","volume":"57","author":"Kyrle","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12726_bb0130","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1160\/TH10-11-0705","article-title":"Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux","volume":"105","author":"Wolzt","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12726_bb0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0735-1097(02)02868-1","article-title":"Effects of ximelagatran, an oral direct thrombin inhibitor, r\u2010hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects","volume":"41","author":"Sarich","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12726_bb0140","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(83)91911-6","article-title":"Thromboxane A2 in skin\u2010bleeding\u2010time blood and in clotted venous blood before and after administration of acetylsalicylic acid","volume":"1","author":"Thorngren","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/jth.12726_bb0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood.V71.3.629.629","article-title":"Evidence for tissue factor\u2010dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds","volume":"71","author":"Weiss","year":"1988","journal-title":"Blood"},{"key":"10.1111\/jth.12726_bb0150","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.ATV.19.7.1757","article-title":"Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo","volume":"19","author":"Weltermann","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12726_bb0155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2362.2010.02299.x","article-title":"Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans","volume":"40","author":"Lubsczyk","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/jth.12726_bb0160","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V98.8.2423","article-title":"Blood coagulation at the site of microvascular injury: effects of low\u2010dose aspirin","volume":"98","author":"Undas","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.12726_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0049-3848(00)00226-7","article-title":"A novel enzyme immunoassay for plasma thrombospondin. Comparison with beta\u2010thromboglobulin as platelet activation marker in vitro and in vivo","volume":"99","author":"Bergseth","year":"2000","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12726_bb0170","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood.V88.9.3432.bloodjournal8893432","article-title":"Blood clotting in minimally altered whole blood","volume":"88","author":"Rand","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.12726_bb0175","first-page":"71","article-title":"Laboratory markers of coagulation activation","volume":"117","author":"Bauer","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.12726_bb0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V34.2.204.204","article-title":"The standardized normal Ivy bleeding time and its prolongation by aspirin","volume":"34","author":"Mielke","year":"1969","journal-title":"Blood"},{"key":"10.1111\/jth.12726_bb0185","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0735-1097(99)00023-6","article-title":"Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia","volume":"33","author":"Szczeklik","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12726_bb0190","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00228-005-0043-5","article-title":"Safety, pharmacodynamics, and pharmacokinetics of BAY 59\u20107939\u2013an oral, direct Factor Xa inhibitor\u2013after multiple dosing in healthy male subjects","volume":"61","author":"Kubitza","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jth.12726_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2005-869525","article-title":"Preclinical and clinical studies with selective reversible direct P2Y12 antagonists","volume":"31","author":"van Giezen","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12726_bb0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2141.1994.tb05078.x","article-title":"Thrombin binding to platelets and their activation in plasma","volume":"88","author":"Liu","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12726_bb0205","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic\u2010drug regimens after coronary\u2010artery stenting. Stent Anticoagulation Restenosis Study Investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12726_bb0210","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/01.ATV.15.7.886","article-title":"Effects of recombinant hirudin (r\u2010hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low\u2010molecular\u2010weight heparin preparation (fragmin)","volume":"15","author":"Eichinger","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12726_bb0215","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4244\/EIJV8I9A162","article-title":"A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients","volume":"8","author":"Vranckx","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1111\/jth.12726_bb0220","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jth.12591","article-title":"Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor\u2010induced hypercoagulability in vitro and in vivo","volume":"12","author":"Perzborn","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12726_bb0225","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/dmd.113.053561","article-title":"Impact of endogenous esterase activity on in vitro p\u2010glycoprotein profiling of dabigatran etexilate in Caco\u20102 monolayers","volume":"42","author":"Ishiguro","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jth.12726_bb0230","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00228-013-1543-3","article-title":"A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers","volume":"69","author":"Teng","year":"2013","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12726","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12726","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622041058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622041058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12726\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:09:41Z","timestamp":1761534581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622041058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1538783622041058"],"URL":"https:\/\/doi.org\/10.1111\/jth.12726","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}